CANY
SHC icon

Caxton Associates (New York)’s Sotera Health SHC Stock Holding History

Caxton Associates (New York)’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-32,695
Closed -$223K – 589
2022
Q3 		$223K Buy
+32,695
New +$544K 0.03% 380

Other funds holding SHC

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MC
MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Caxton Associates (New York)'s SHC Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Sotera Health (SHC) in Q4 2022, closing a stake of 32,695 shares — an estimated $223K sold.

Caxton Associates (New York) first reported a position in SHC in Q3 2022 and held it in 1 quarter. The position peaked at $223K in Q3 2022. 172 funds tracked by Wall St. Rank hold SHC as of Q4 2022.

  • Caxton Associates (New York) reported no remaining Sotera Health position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 32,695 Sotera Health shares in Q4 2022, an estimated $223K.
  • Caxton Associates (New York) first reported a position in Sotera Health in Q3 2022 and held it in 1 quarter.
  • Caxton Associates (New York)'s Sotera Health position peaked at $223K in Q3 2022.
  • 172 funds tracked by Wall St. Rank held Sotera Health as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.